Axon Enterprise Inc vs Regeneron Pharmaceuticals Inc — how do they compare? Axon Enterprise Inc trades at $631 (market cap $51.69B), while Regeneron Pharmaceuticals Inc trades at $796.38 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is the larger of the two by market cap, and Regeneron Pharmaceuticals Inc pays a 0.47% dividend while Axon Enterprise Inc pays none. Which is the better fit depends on your goals.
| AXON | REGN | |
|---|---|---|
Market Cap | $51.69B | $82.06B |
Sector | Technology | Health |
52-Week High | $791.62 | $812.27 |
52-Week Low | $345.94 | $555.51 |
Enterprise Value | $52.83B | $76.77B |
Dividend Yield | — | 0.47% |
Trailing returns across standard periods
Latest headlines on both assets
Axon develops technology and weapons for law enforcement and military use. Its ecosystem includes TASER devices, body cameras, and Evidence.com, a cloud-based platform for digital evidence management.
Read more on AXON →Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →